Artal Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-400,000
| Closed | -$2.36M | – | 133 |
|
|
2022
Q4 | $2.36M | Hold |
400,000
| – | – | 0.13% | 80 |
|
|
2022
Q3 | $1.28M | Hold |
400,000
| – | – | 0.05% | 102 |
|
|
2022
Q2 | $1.79M | Hold |
400,000
| – | – | 0.1% | 101 |
|
|
2022
Q1 | $2.14M | Hold |
400,000
| – | – | 0.09% | 109 |
|
|
2021
Q4 | $5.88M | Hold |
400,000
| – | – | 0.16% | 91 |
|
|
2021
Q3 | $8.36M | Hold |
400,000
| – | – | 0.19% | 84 |
|
|
2021
Q2 | $7.08M | Buy |
400,000
+300,000
| +300% | +$5.31M | 0.14% | 104 |
|
|
2021
Q1 | $2.45M | Hold |
100,000
| – | – | 0.04% | 125 |
|
|
2020
Q4 | $3.39M | Sell |
100,000
-42,500
| -30% | -$1.44M | 0.07% | 108 |
|
|
2020
Q3 | $3.56M | Sell |
142,500
-7,500
| -5% | -$188K | 0.09% | 95 |
|
|
2020
Q2 | $5.06M | Buy |
+150,000
| New | +$5.06M | 0.14% | 89 |
|